Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection

Clinical trial NCT06953271 · RECRUITING

Trial details

NCT number: NCT06953271
Sponsor: Women and Infants Hospital of Rhode Island
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Overactive Bladder (OAB)Urinary Tract Infection (Diagnosis)

Start date: 2025-08-01
Primary completion: 2027-01-30
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.